• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌根治性切除术后1年内复发风险列线图模型的构建与验证

Construction and Validation of a Recurrent Risk Nomogram Model for Non-Small Cell Lung Cancer within 1 Year after Radical Resection.

作者信息

Zeng Dechuang, Tang Xiqiang, Nong Feng, Yi Jinyuan, Yao Yuanxi, Luo Shiguan

机构信息

Department of Cardiothoracic Vascular Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities of Baise, Guangxi 533000, China.

出版信息

J Oncol. 2022 Jul 19;2022:8967162. doi: 10.1155/2022/8967162. eCollection 2022.

DOI:10.1155/2022/8967162
PMID:35909898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9325597/
Abstract

OBJECTIVE

To explore the risk factors of recurrence within 1 year after radical resection of non-small cell lung cancer (NSCLC) and construct the nomogram model.

METHODS

The clinical data of 186 patients with NSCLC treated with radical surgery in Affiliated Hospital of Youjiang Medical University for Nationalities of Baise were retrospectively analyzed. Multivariate logistic regression was applied to analyze the risk factors of recurrence within 1 year after radical resection of NSCLC. The R language (R 4.0.3 software package) was used in constructing the nomogram model, and the predictive value of the model was evaluated.

RESULTS

The recurrence rate of 186 patients within 1 year after radical surgery was 29.57%. After multivariate logistic regression analysis, pathological stage, number of lymph node metastasis, chronic obstructive pulmonary disease (COPD), postoperative plasma D-dimer, and carcinoembryonic antigen were independent factors for recurrence within 1 year after radical resection of NSCLC ( < 0.05). Based on the above independent risk factors, a nomogram model was established, with the distinction of AUC = 0.891 (95% CI: 0.819-0.964) and sensitivity and specificity of 70.3% and 97.8%, respectively. The calibration curve was close to the ideal curve. External validation of the model showed AUC = 0.801 (95% CI: 0.674-0.928), and sensitivity and specificity were 66.7% and 84.2%, respectively.

CONCLUSION

The recurrence of NSCLC within 1 year after radical surgery was related to a variety of factors, and the nomogram model constructed based on risk factors had good goodness of fit, calibration, consistency of prediction, and prediction efficiency.

摘要

目的

探讨非小细胞肺癌(NSCLC)根治性切除术后1年内复发的危险因素并构建列线图模型。

方法

回顾性分析百色右江民族医学院附属医院186例行根治性手术的NSCLC患者的临床资料。采用多因素logistic回归分析NSCLC根治性切除术后1年内复发的危险因素。运用R语言(R 4.0.3软件包)构建列线图模型并评估模型的预测价值。

结果

186例患者根治性手术后1年内的复发率为29.57%。多因素logistic回归分析显示,病理分期、淋巴结转移数目、慢性阻塞性肺疾病(COPD)、术后血浆D-二聚体及癌胚抗原是NSCLC根治性切除术后1年内复发的独立因素(<0.05)。基于上述独立危险因素建立列线图模型,其AUC为0.891(95%CI:0.819-0.964),敏感度和特异度分别为70.3%和97.8%。校准曲线接近理想曲线。模型的外部验证显示AUC为0.801(95%CI:0.674-0.928),敏感度和特异度分别为66.7%和84.2%。

结论

NSCLC根治性手术后1年内的复发与多种因素有关,基于危险因素构建的列线图模型具有良好的拟合优度、校准度、预测一致性和预测效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/1a71ad81198f/JO2022-8967162.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/89fb85e25204/JO2022-8967162.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/c7ffe458ef21/JO2022-8967162.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/1a71ad81198f/JO2022-8967162.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/89fb85e25204/JO2022-8967162.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/c7ffe458ef21/JO2022-8967162.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ba/9325597/1a71ad81198f/JO2022-8967162.003.jpg

相似文献

1
Construction and Validation of a Recurrent Risk Nomogram Model for Non-Small Cell Lung Cancer within 1 Year after Radical Resection.非小细胞肺癌根治性切除术后1年内复发风险列线图模型的构建与验证
J Oncol. 2022 Jul 19;2022:8967162. doi: 10.1155/2022/8967162. eCollection 2022.
2
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
3
[Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].[新辅助治疗直肠癌患者腹腔镜手术后吻合口漏的危险因素分析及列线图预测模型的建立]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Aug 25;22(8):748-754. doi: 10.3760/cma.j.issn.1671-0274.2019.08.009.
4
Risk factor analysis and nomogram prediction model construction of postoperative complications of thoracoscopic non-small cell lung cancer.胸腔镜非小细胞肺癌术后并发症的危险因素分析及列线图预测模型构建
J Thorac Dis. 2024 Jun 30;16(6):3655-3667. doi: 10.21037/jtd-24-113. Epub 2024 Jun 12.
5
[A nomogram for predicting lymph node metastasis in early gastric cancer].[一种预测早期胃癌淋巴结转移的列线图]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jan 25;25(1):40-47. doi: 10.3760/cma.j.cn441530-20210208-00059.
6
Risk factors for postoperative pulmonary infection in patients with non-small cell lung cancer: analysis based on regression models and construction of a nomogram prediction model.非小细胞肺癌患者术后肺部感染的危险因素:基于回归模型的分析及列线图预测模型的构建
Am J Transl Res. 2023 May 15;15(5):3375-3384. eCollection 2023.
7
Development and validation of a prognostic nomogram for colorectal cancer after surgery.一种用于结直肠癌术后的预后列线图的开发与验证
World J Clin Cases. 2021 Jul 26;9(21):5860-5872. doi: 10.12998/wjcc.v9.i21.5860.
8
Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.基于预后营养指数和胸部 CT 影像学特征的列线图预测 NSCLC 患者的淋巴结转移。
J Xray Sci Technol. 2022;30(3):599-612. doi: 10.3233/XST-211080.
9
[Establishment of a nomogram model for predicting lymph node metastasis in patients with cN0 gastric cancer based on combination of preoperative C-reactive protein/albumin ratio].[基于术前C反应蛋白/白蛋白比值联合建立预测cN0期胃癌患者淋巴结转移的列线图模型]
Zhonghua Zhong Liu Za Zhi. 2019 Aug 23;41(8):599-603. doi: 10.3760/cma.j.issn.0253-3766.2019.08.008.
10
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.用于预测无复发生存率并分析化疗在ⅠB期非小细胞肺癌中效用的列线图。
Transl Lung Cancer Res. 2022 Jan;11(1):75-86. doi: 10.21037/tlcr-21-1038.

本文引用的文献

1
Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients.血浆 D-二聚体水平与非小细胞肺癌(NSCLC)患者的年龄、转移、复发、肿瘤-淋巴结-转移(TNM)分类和治疗相关。
Biomed Res Int. 2021 Oct 19;2021:9623571. doi: 10.1155/2021/9623571. eCollection 2021.
2
CT-Based Sarcopenic Nomogram for Predicting Progressive Disease in Advanced Non-Small-Cell Lung Cancer.基于CT的肌肉减少症列线图预测晚期非小细胞肺癌的疾病进展
Front Oncol. 2021 Oct 8;11:643941. doi: 10.3389/fonc.2021.643941. eCollection 2021.
3
Acupuncture against chronic postsurgical pain in non-small cell lung cancer patients: A protocol of randomized controlled trial.
针刺治疗非小细胞肺癌患者慢性术后疼痛的随机对照试验方案。
Medicine (Baltimore). 2021 Oct 8;100(40):e27461. doi: 10.1097/MD.0000000000027461.
4
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.术后放疗对完全切除术后辅助化疗的 pIIIA-N2 期非小细胞肺癌患者的影响:III 期 PORT-C 随机临床试验。
JAMA Oncol. 2021 Aug 1;7(8):1178-1185. doi: 10.1001/jamaoncol.2021.1910.
5
Clinical significance of C-Reactive Protein to Lymphocyte Count Ratio as a prognostic factor for Survival in Non-small Cell Lung Cancer Patients undergoing Curative Surgical Resection.C反应蛋白与淋巴细胞计数比值作为接受根治性手术切除的非小细胞肺癌患者生存预后因素的临床意义
J Cancer. 2021 May 27;12(15):4497-4504. doi: 10.7150/jca.58094. eCollection 2021.
6
Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer.非小细胞肺癌术后胸段寡复发/转移的挽救性立体定向体部放疗的临床结局及预后因素
Cancer Manag Res. 2021 Feb 23;13:1887-1896. doi: 10.2147/CMAR.S287993. eCollection 2021.
7
A biomarker-based prediction model for risk of locoregional recurrence in pathologic stage IIIA-N2 non-small cell lung cancer.基于生物标志物的ⅢA-N2期非小细胞肺癌局部区域复发风险预测模型
Int J Clin Exp Pathol. 2020 Dec 1;13(12):3060-3082. eCollection 2020.
8
Risk factors of postoperative recurrence and potential candidate of adjuvant radiotherapy in lung adenosquamous carcinoma.肺腺鳞癌术后复发的危险因素及辅助放疗的潜在候选对象
J Thorac Dis. 2020 Oct;12(10):5593-5602. doi: 10.21037/jtd-20-1979.
9
Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non-Small Cell Lung Cancer.血清铁蛋白、癌胚抗原和C反应蛋白联合检测在非小细胞肺癌中的诊断价值
Cancer Manag Res. 2020 Sep 22;12:8813-8819. doi: 10.2147/CMAR.S268565. eCollection 2020.
10
Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma.接受根治性切除术的胰腺导管腺癌患者凝血活性的预后影响。
In Vivo. 2020 Sep-Oct;34(5):2845-2850. doi: 10.21873/invivo.12111.